Stock Events

Coloplast A/S 

kr777.6
38
-kr1-0.13% Today

Statistics

Day High
785.6
Day Low
774.2
52W High
993
52W Low
689.2
Volume
186,552
Avg. Volume
210,948
Mkt Cap
179.48B
P/E Ratio
38.36
Dividend Yield
2.7%
Dividend
20.97

Upcoming

Dividends

2.7%Dividend Yield
Dec 23
kr16
May 23
kr5
Dec 22
kr15
May 22
kr5
Dec 21
kr14

Earnings

9FebExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
0
0.03
0.06
0.1
Expected EPS
0.0874
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow COLO-B.CO. It's not an investment recommendation.

About

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates in three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Show more...
CEO
Mr. Kristian Villumsen
Employees
14000
Country
DK
ISIN
DK0060448595
WKN
000A1KAGC

Listings